Andersons, Inc. (The) Common Stock (ANDE) Technical Analysis
$66.97▲0.27%
Market is closed - opens 7 PM, 28 Sep 2026
Insights
- Andersons Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Andersons Inc. stock suggests that it is a good time to buy
- Based on analysis of the Moving Averages technical indicator, Andersons Inc. stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Andersons Inc. stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 42.67 | Neutral |
Stochastic | 19.55, 15.35 | Buy |
Ultimate Oscillator | 46.85 | Neutral |
Stochastic Relative Strength Index | 4.64, 3.69 | Buy |
Moving Average Convergence Divergence | -0.33, 0.08 | Sell |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 69.26 | Buy |
20 | 69.2 | Sell |
50 | 69.82 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 68.43 | Sell |
20 | 68.8 | Sell |
50 | 69.48 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 69.44 | Neutral |
20 | 69.17 | Neutral |
50 | 69.81 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 67.58 | Sell |
20 | 68.5 | Buy |
50 | 68.13 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 66.66 | Sell |
20 | 68.41 | Buy |
50 | 68.27 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 68.69 |
Resistance L2 | 68.14 |
Resistance L1 | 67.46 |
Pivot Point | 66.91 |
Support L1 | 66.23 |
Support L2 | 65.68 |
Support L3 | 65.0 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.